Main topic | Basic structural elements | References (DA) |
---|---|---|
Target group | Women with BRCA1/2 mutation | |
Women at high risk of breast cancer | ||
Women at high risk of ovarian cancer | ||
Addressed target decision | Preventive options related to breast and ovarian cancer | [58] |
Preventive options only/mainly related to breast cancer | ||
Preventive options only/mainly related to ovarian cancer | ||
Medical information | Family history of breast and/or ovarian cancer (explanations, even if brief) | |
Impact of a pathogenic BRCA1/2 mutation (reason for high risk of breast and/or ovarian cancer) | ||
Average morbidity rates for breast and/or ovarian cancer (text and/or number values and/or graphics) | ||
(a) Lifetime risks | ||
(b) Time and/or age-related morbidity rates | ||
Preventive options (explanations, even if brief) | ||
Outcomes with and without preventive measure (text and/or number values and/or graphics) | ||
Consequences of the different preventive measures (text and/or number values and/or graphics) | ||
Hormone replacement therapy to counteract consequences of risk-reducing removal of both ovaries and Fallopian tubes | ||
Benefits and risks of the different preventive measures and/or comparison of the options (option grid) | ||
Personal stories (testimonies) | ||
Appendix with fact boxes | ||
Tools for decision-making support | General information on dealing with decision-making | |
Step-by-step guide to decision-making | ||
Tools to assist with clarifying own values and preferences, e.g To reflect on personal opinions regarding the advantages and disadvantages of the options by answering set response options (box-ticking) and/or using note spaces for free-form reflections To reflect on the current tendency towards or against a certain option | ||
Question lists addressing medical information and/or doctor-patient dialogue | ||
Other | Glossary | |
Contact addresses and/or internet links | ||
References, further literature |